James Seibold, MD
Scleroderma Research Consultants LLC · Scleroderma Research Consultants LLC, Avon, CT, · Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James Seibold, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:57 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00848107 · Open-Label Study of Oral Treprostinil in Digital UlcersUnited Therapeutics · terminated · Systemic Sclerosis · principal investigator
- Ph2NCT00775463 · Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil DiethanolamineUnited Therapeutics · completed · Systemic Sclerosis, Scleroderma · principal investigator
- Ph3NCT00077584 · Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With SclerodermaActelion · completed · Digital Ulcers, Systemic Sclerosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 17 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- ROLE OF LEUKOTRIENES IN HUMORAL AND CELLULAR IMMUNITYR01AM034672 · NIADDK · UNIVERSITY OF NEW MEXICO · fiscal years 1985 · $25,012 awarded in 1985Same name and institution; not confirmed by an ID
- ROLE OF PROSTAGLANDIN IN THE IMMUNOBIOLOGY OF AGINGR01AG001245 · NIA · UNIVERSITY OF NEW MEXICO · fiscal years 1985 · $92,784 awarded in 1985Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.